Oxford, UK-based PharmaVentures – a firm which provides database, analysis tools, and reports to the pharma and biotech sectors – has formed an agreement with US-based MR firm Growthink Research to roll out the latter’s Venture Capital database to industry and academic customers worldwide.
Growthink Research specializes in tracking and analyzing venture capital activity, and has detailed information on more than 8,800 US-based, venture-funded companies in its database.
Said CEO Corey Lavinsky: ‘Our data is an invaluable resource for companies looking to raise capital or to identify new clients. Working with PharmaVentures will help us target new markets internationally that have a strong and persistent demand for this high quality financial information.’
PharmaVentures' CEO Fintan Walton says that the Growthink database complements his firm’s own proprietary PharmaDeals database, which provides information on, and analysis of deal making in the pharmaceutical industry.
